Suppr超能文献

静止期Graves眼病的亚临床眼球运动功能障碍和眼外肌改变

Subclinical Ocular Motility Dysfunction and Extraocular Muscle Changes in Inactive Graves' Orbitopathy.

作者信息

Lixi Filippo, Cuccu Alberto, Giannaccare Giuseppe, Onnis Matteo, Timofte Zorila Mihaela Madalina, Mariotti Stefano, Vacca Rosanna, Meloni Paola Elisa, Pisu Michela, Mura Chiara, Boi Francesco

机构信息

Eye Clinic, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.

Department of Ophthalmology, Cai Ferate Clinical Hospital, 1 Garabet Ibraileanu Street, 700506 Iasi, Romania.

出版信息

J Pers Med. 2024 Aug 10;14(8):848. doi: 10.3390/jpm14080848.

Abstract

This study aimed to investigate the presence of structural and functional changes in extraocular muscles (EMs) among patients with inactive Graves' orbitopathy (GO) classified according to the Clinical Activity Score (CAS). Sixty-seven patients with Graves' disease (GD) and inactive GO were included. The data collected included clinical parameters, thyroid function, autoantibody levels, EOM morphology via orbital ultrasound (US), and ocular motility. Patients were stratified into Red Filter Test (RFT)-positive or RFT-negative groups based on the presence or absence of latent diplopia during the RFT examination. Thirty-three patients (49.25%) exhibited latent diplopia on the RFT, despite not reporting double vision during standard ocular motility tests. Significant differences were observed between the two groups in terms of age, disease duration, intraocular pressure (IOP) elevation in up-gaze, and medial rectus muscle thickness ( < 0.05). No significant differences were found in thyroid status, TRAb and ATA levels, CASs, exophthalmos, or lateral rectus thickness between the two groups. This study revealed that in inactive GO, subclinical EM dysfunction and morphological changes may be present, which might not be apparent through routine ocular examinations. The RFT is effective in detecting latent diplopia, highlighting its utility in identifying subtle ocular motility issues and subclinical muscle involvement. Comprehensive evaluations combining functional tests like the RFT and imaging are essential for early detection of GO-related abnormalities, enabling tailored and prompt management and improving patient outcomes.

摘要

本研究旨在调查根据临床活动评分(CAS)分类的静止期格雷夫斯眼眶病(GO)患者眼外肌(EM)的结构和功能变化情况。纳入了67例格雷夫斯病(GD)合并静止期GO患者。收集的数据包括临床参数、甲状腺功能、自身抗体水平、通过眼眶超声(US)测量的眼外肌形态以及眼球运动情况。根据红色滤光片试验(RFT)检查中是否存在潜在复视,将患者分为RFT阳性或RFT阴性组。33例患者(49.25%)在RFT检查中表现出潜在复视,尽管在标准眼球运动测试中未报告复视。两组在年龄、病程、上视时眼压(IOP)升高以及内直肌厚度方面存在显著差异(<0.05)。两组在甲状腺状态、促甲状腺素受体抗体(TRAb)和抗甲状腺过氧化物酶抗体(ATA)水平、CAS、眼球突出度或外直肌厚度方面未发现显著差异。本研究表明,在静止期GO中,可能存在亚临床眼外肌功能障碍和形态学变化,而这些变化通过常规眼部检查可能并不明显。RFT在检测潜在复视方面有效,突出了其在识别细微眼球运动问题和亚临床肌肉受累方面的实用性。将RFT等功能测试与影像学相结合的综合评估对于早期发现GO相关异常至关重要,能够实现针对性的及时管理并改善患者预后。

相似文献

2
Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves' Orbitopathy.
Ophthalmol Ther. 2024 Apr;13(4):1015-1024. doi: 10.1007/s40123-024-00892-4. Epub 2024 Feb 20.
3
Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions.
Thyroid. 2021 Feb;31(2):280-287. doi: 10.1089/thy.2020.0165. Epub 2020 Oct 22.
4
Orbital diseases mimicking graves' orbitopathy: a long-standing challenge in differential diagnosis.
J Endocrinol Invest. 2020 Apr;43(4):401-411. doi: 10.1007/s40618-019-01141-3. Epub 2019 Nov 5.
5
Is modified clinical activity score an accurate indicator of diplopia progression in Graves' orbitopathy patients?
Endocr J. 2016 Dec 30;63(12):1133-1140. doi: 10.1507/endocrj.EJ16-0165. Epub 2016 Sep 13.
6
Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
Eur J Endocrinol. 2000 Jun;142(6):591-7. doi: 10.1530/eje.0.1420591.
8
Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):991-8. doi: 10.1007/s00417-016-3280-7. Epub 2016 Feb 15.
9
Factors associated with severity of orbitopathy in patients with Graves' disease.
Taiwan J Ophthalmol. 2020 May 4;10(3):197-202. doi: 10.4103/tjo.tjo_10_20. eCollection 2020 Jul-Sep.
10
Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement.
Graefes Arch Clin Exp Ophthalmol. 2022 Dec;260(12):3977-3984. doi: 10.1007/s00417-022-05760-0. Epub 2022 Jul 14.

本文引用的文献

1
Thyroid Eye Disease: Advancements in Orbital and Ocular Pathology Management.
J Pers Med. 2024 Jul 22;14(7):776. doi: 10.3390/jpm14070776.
3
Thyroid Eye Disease.
Mo Med. 2022 Jul-Aug;119(4):343-350.
4
Current concepts regarding Graves' orbitopathy.
J Intern Med. 2022 Nov;292(5):692-716. doi: 10.1111/joim.13524. Epub 2022 Jun 1.
5
Sample size determination and power analysis using the G*Power software.
J Educ Eval Health Prof. 2021;18:17. doi: 10.3352/jeehp.2021.18.17. Epub 2021 Jul 30.
7
Selenium in the Treatment of Graves' Hyperthyroidism and Eye Disease.
Front Endocrinol (Lausanne). 2021 Jan 26;11:608428. doi: 10.3389/fendo.2020.608428. eCollection 2020.
8
The Effect of Inferior Rectus Muscle Thickening on Intraocular Pressure in Thyroid-Associated Ophthalmopathy.
J Ophthalmol. 2021 Jan 29;2021:9736247. doi: 10.1155/2021/9736247. eCollection 2021.
9
Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment.
Curr Opin Neurol. 2021 Feb 1;34(1):116-121. doi: 10.1097/WCO.0000000000000894.
10
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy.
J Endocrinol Invest. 2021 Mar;44(3):581-585. doi: 10.1007/s40618-020-01353-y. Epub 2020 Jul 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验